Kaletra and Maraviroc in Antiretroviral Therapy-Naive Patients - KALMAR Study -Version 1.0 Amendment 2.
Phase of Trial: Phase IV
Latest Information Update: 16 Jul 2014
At a glance
- Drugs Lopinavir/ritonavir (Primary) ; Maraviroc (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- Acronyms KALMAR
- 07 Jun 2017 Biomarkers information updated
- 05 Jun 2014 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov record.
- 23 Sep 2010 Actual initiation date (Apr 2010) added as reported by ClinicalTrials.gov.